Sunakawa Y, Nakamura M, Ishizaki M, Kataoka M, et al. RAS mutations in circulating tumor DNA (ctDNA) and clinical outcomes of rechallenge treatments with anti-EGFR antibodies in patients with metastatic colorectal cancer (mCRC). Ann Oncol 2019;30 Suppl 4:iv114.
PMID: 32084981